Zacks Investment Research upgraded shares of BioScrip, Inc. (BIOS) from NEUTRAL to OUTPERFORM on April 09, 2013, with a target price of $15.00.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on BioScrip, Inc. (BIOS),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment